Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials
Dewan Md. Sumsuzzman, Jeong‐Hyun Choi, Yunho Jin, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 459-473
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Circadian disruption and human health
Anna Fishbein, Kristen L. Knutson, Phyllis C. Zee
Journal of Clinical Investigation (2021) Vol. 131, Iss. 19
Open Access | Times Cited: 232
Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder
Ágnes Szabó, Zsolt Galla, Eleonóra Spekker, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Qí Zhāng, Xi‐min Hu, Wenjuan Zhao, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 658-674
Open Access | Times Cited: 35
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
Christopher D. Morrone, Radha Raghuraman, S. Abid Hussaini, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 27
Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer’s disease
Sonal Dubey, Ekta Singh
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 717-730
Closed Access | Times Cited: 25
Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer’s dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy
Ping‐Tao Tseng, Bing‐Syuan Zeng, Mein‐Woei Suen, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 352-364
Open Access | Times Cited: 25
Melatonin: A potential nighttime guardian against Alzheimer’s
Z Zhang, Pei Xue, Barbara B. Bendlin, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 11
Data Mining Approach to Melatonin Treatment in Alzheimer’s Disease: New Gene Targets MMP2 and NR3C1
Jingyi Zhang, Ka Chun Tsui, Hoi Ying Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 338-338
Open Access | Times Cited: 1
Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews
Reza Majidazar, Erfan Rezazadeh‐Gavgani, Saeed Sadigh‐Eteghad, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 10, pp. 1567-1587
Closed Access | Times Cited: 36
Possible Application of Melatonin in Long COVID
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1646-1646
Open Access | Times Cited: 31
Chronic Administration of Melatonin: Physiological and Clinical Considerations
Donald Givler, Amy Givler, Patrick M. Luther, et al.
Neurology International (2023) Vol. 15, Iss. 1, pp. 518-533
Open Access | Times Cited: 21
Extracellular vesicles ameliorates sleep deprivation induced anxiety-like behavior and cognitive impairment in mice
Yiqin Lin, Zhen-Ming Kang, Changsheng Su, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 1, pp. 101207-101207
Open Access | Times Cited: 8
Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis
Itsuki Terao, Wakako Kodama
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 3, pp. 825-835
Closed Access | Times Cited: 6
It’s About Time: The Circadian Network as Time-Keeper for Cognitive Functioning, Locomotor Activity and Mental Health
Müge Yalçin, Annakarina Mundorf, Freya Thiel, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 26
Melatonin in ventricular and subarachnoid cerebrospinal fluid: Its function in the neural glymphatic network and biological significance for neurocognitive health
Russel J. Reıter, Ramaswamy Sharma, Sergio Rosales‐Corral, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 605, pp. 70-81
Closed Access | Times Cited: 25
Melatonin: Potential avenue for treating iron overload disorders
Jiancheng Yang, Qinghua Tang, Yuhong Zeng
Ageing Research Reviews (2022) Vol. 81, pp. 101717-101717
Closed Access | Times Cited: 23
Melatonin alleviates oxidative stress damage in mouse testes induced by bisphenol A
Qi Qi, Jiaxin Yang, Shuang Li, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Oxidative Stress in Alzheimer’s Disease: The Shortcomings of Antioxidant Therapies
Miguel A. Pappolla, Ralph N. Martins, Burkhard Pöeggeler, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S155-S178
Closed Access | Times Cited: 5
Melatonin regulates microglial polarization to M2 cell via RhoA/ROCK signaling pathway in epilepsy
Pingping Li, Xuefei Ji, Ming Shan, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 11
Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
Aditi Giri, Sidharth Mehan, Zuber Khan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 6, pp. 3867-3895
Closed Access | Times Cited: 4
CSF proteomic profiling with amyloid/tau positivity identifies distinctive sex-different alteration of multiple proteins involved in Alzheimer’s disease
Anh N., Muhammad Ali, Jigyasha Timsina, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Melatonin in Alzheimer’s Disease: Literature Review and Therapeutic Trials
Marilyn Steinbach, Natalie L. Denburg
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S193-S204
Closed Access | Times Cited: 4
Sleep–wake modulation and pathogenesis of Alzheimer disease: Suggestions for postponement and treatment
Ya-Jing Liu, Dick F. Swaab, Jiang-Ning Zhou
Handbook of clinical neurology (2025), pp. 211-229
Closed Access
A Meta-Analysis of Melatonin Effects on Behavior of Rats Kept in Standard Conditions
N. V. Kuzmenko, В. А. Цырлин, М. Г. Плисс, et al.
Journal of Evolutionary Biochemistry and Physiology (2025) Vol. 61, Iss. 1, pp. 74-95
Closed Access
Age-related memory decline is accelerated by pinealectomy in young adult and middle-aged rats via BDNF / ERK / CREB signalling
Jana Tchekalarova, Dimitrinka Atanasova, Desislava Krushovlieva, et al.
Neurochemistry International (2025) Vol. 185, pp. 105960-105960
Closed Access
Page 1 - Next Page

Scroll to top